Research aims to assess utility of PET tracer in MS imaging

10/2/2013 | Herald (Rock Hill, S.C.), The

GE Healthcare is partnering with the National Multiple Sclerosis Society to fund a clinical trial evaluating the use of GE180, GE's investigational PET imaging agent, in multiple sclerosis patients. The trial is meant to determine whether evaluating MS patients for neuroinflammation -- using PET with GE180 -- before and after natalizumab therapy can pinpoint patients who might benefit from the treatment.

View Full Article in:

Herald (Rock Hill, S.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ